PDX-MI specification paper published

Patient-derived xenografts (PDX) models are an important oncology research tool for the study of tumours. They are created by implanting tumours from cancer patients into a ‘transplant-compliant’ mouse host. PDX are thought to better reflect the heterogeneity of tumours than cell lines or transgenic animal ...

Patient-Derived Xenograft models undergo mouse-specific tumour evolution

PDX models are in vivo systems to study human cancers and tumour therapies. Identifying the correct PDX models for developing drug targets is not an easy task for oncologists. A recent scientific publication in Nature Genetics has highlighted the importance of cataloguing the molecular characterisation ...

The Highlights of ASHG 2017 Industry / Exhibits

October 17th-21st Orange County Convention Center Orlando, Florida Scientific highlights tend to have extensive coverage. In this blog post we provide an overview of the industry / exhibitors that were part of the American Association of Human Genetics (ASHG) 2017 while representing Repositive. Method: We took ...

2017 GA4GH Plenary Meeting Highlights

October 15-17, Hilton Orlando, Florida Repositive is pleased to participate and contribute to the Global Alliance for Genomics and Health (GA4GH) as one of its members. GA4GH’s Plenary Meeting held on October 15-17th 2017 was the chosen venue to announce the new vision for ...

A brief summary of ‘Genomic Medicine 2017 Cambridge’ 26-27 September

I am happy to give a brief summary of most presentations that formed part of the program of the ‘Genomic Medicine Conference 2017 Cambridge’, just being held on September 26-27th at the Murray Edwards College in Cambridge, UK. It was organised by Biotexcel. It was ...